| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2014-11-17 | Merrimack Pharmaceuticals (USA - MA) | member of the board of directors | nomination | Cancer - Oncology | Nomination | |
| 2014-11-14 | Newlink Genetics (USA - IO) | chief scientific officer | nomination | Cancer - Oncology - Infectious diseases | Nomination | |
| 2014-11-13 | Topotarget (Denmark), now Onxeo (France) Spectrum Pharmaceuticals (USA - CA) | Beleodaq® (belinostat) | peripheral T-cell lymphoma | licensing |
Cancer - Oncology | Milestone |
| 2014-11-13 | Saniona (Denmark) Syngene (India) | AN363 | neuropathic pain | CNS diseases | Development agreement | |
| 2014-11-13 | Philips (The Netherlands) | healthcare imaging systems refurbishment facility in Best | opening of new premises | Technology - Services | Opening of new premises | |
| 2014-11-13 | Janssen Biotech, a J&J company (USA - NJ) - Geron (USA - CA) | imetelstat | myelofibrosis, myelodysplastic syndrome, acute myelogenous leukemia, hematologic myeloid malignancies | development licensing collaboration commercialisation |
Cancer - Oncology | Licensing agreement |
| 2014-11-12 | Athera Biotechnologies (Sweden) Boehringer Ingelheim (Germany) | antibody program PC-mAb | cardiovascular diseases | R&D |
Cardiovascular diseases | Termination of an agreement |
| 2014-11-12 | Abbvie (USA - IL) Enterome Bioscience (France) | non-invasive monitoring tools of the gut microbiome | Crohn's disease | development |
Autoimmune diseases - Inflammatory diseases - Digestive diseases | Development agreement |
| 2014-11-12 | Medgenics (USA-Israel) The Children\'s Hospital of Philadelphia (USA - PA) | pediatric rare and orphan genetic diseases | R&D |
Genetic diseases - Pediatric diseases - Rare diseases | R&D agreement | |
| 2014-11-12 | Diaxonhit (France) One Lambda (USA - CA) | HLA1 typing tests for transplantation | transplantation | commercialisation |
Transplantation - Diagnostic | Commercialisation agreement |
| 2014-11-12 | New Oncology (Germany) National Cancer Centre Singapore (NCCS) (Singapore) | diagnostic platform ‘NEO’ | collaboration |
Cancer - Oncology | Collaboration agreement | |
| 2014-11-12 | Abivax (France) the Finlay Institute (Cuba) | vax-TyVi, VA-MENGOC-BC, vax-SPIRAL | typhoid, meningococcus, and leptospirosis | collaboration |
Infectious diseases | Collaboration agreement |
| 2014-11-11 | GE Healthcare (USA - WI) Takeda Pharmaceutical (Japan) | hepatic fibrosis, NAFLD (non-alcoholic fatty liver disease), NASH (non-alcoholic steatohepatitis) | R&D |
Liver diseases - Hepatic diseases | R&D agreement | |
| 2014-11-11 | Aveo Oncology (USA - MA) Ophthotech (USA - NY) | tivozanib | non-oncologic diseases of the eye | R&D licensing |
Ophtalmological diseases | R&D agreement |
| 2014-11-11 | Arqule Therapeutics (USA - MA) National Human Genome Research Institute (NHGRI) (USA) | ARQ 092 | Proteus syndrome | development |
Rare diseases | Development agreement |
| 2014-11-11 | Intarcia Therapeutics (USA - MA) Servier (France) | ITCA 650 (exenatide, delivered continuously once or twice yearly through a matchstick-sized, subcutaneous osmotic mini-pump) | type 2 diabetes | development commercialisation |
Metabolic diseases | Development agreement |
| 2014-11-11 | VolitionRx (Singapore) University of Oxford (UK) | Nucleosomics® platform | endometriosis | clinical research |
Gynecological diseases - Women\'s health - Diagnostic | Clinical research agreement |
| 2014-11-11 | Novartis (Switzerland) Qiagen (The Netherlands) | companion diagnostics | development |
Development agreement | ||
| 2014-11-11 | Innate Immunotherapeutics (Australia) | nomination | Autoimmune diseases - Neurodegenerative diseases | Nomination | ||
| 2014-11-10 | Dendreon (USA - WA) | Restructuring |
Cancer - Oncology | Establishment of a new subsidiary in the EU |
